Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis
about
A 2015 roadmap for the management of hepatitis C virus infections in AsiaCoffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-AnalysisClinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study.How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection.
P2860
Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Efficacy and safety of pegylat ...... C genotype 6: a meta-analysis
@ast
Efficacy and safety of pegylat ...... C genotype 6: a meta-analysis
@en
type
label
Efficacy and safety of pegylat ...... C genotype 6: a meta-analysis
@ast
Efficacy and safety of pegylat ...... C genotype 6: a meta-analysis
@en
prefLabel
Efficacy and safety of pegylat ...... C genotype 6: a meta-analysis
@ast
Efficacy and safety of pegylat ...... C genotype 6: a meta-analysis
@en
P2093
P2860
P1433
P1476
Efficacy and safety of pegylat ...... C genotype 6: a meta-analysis
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0100128
P407
P577
2014-06-25T00:00:00Z